Technical Briefing & Evaluation
Evaluate EndoXplain
on your pipeline.
Connect directly with our computational chemistry and regulatory toxicology team to evaluate EndoXplain across your target endpoints.
What to expect in the technical briefing
OECD TG 455 & Endpoint Walkthrough
Review nuclear receptor concordance benchmarks (ERα, AR) and fragment-level SHAP mechanistic attributions on reference or blind chemical scaffolds.
Encrypted Integration Architecture
Evaluate deployment options tailored to your IP posture — from mTLS containerized API connectors to isolated single-tenant environments with zero molecular retention.
Audit-Ready Regulatory Dossier Sample
Inspect full exported Weight-of-Evidence (WoE) dossiers formatted for ANVISA, FDA, and OECD New Approach Methodologies (NAMs) submissions.
Strict IP & Structural Confidentiality
Do not submit confidential SMILES or proprietary chemical structures in this initial form. We execute a standard Mutual Non-Disclosure Agreement (mNDA) prior to any structural evaluation.
Qualification & Briefing Request
All fields are required. Please use your corporate or academic email address.
Briefing Request Prepared
Your evaluation details have been formatted for our scientific team. Click below to dispatch directly via your email client or copy your dossier reference.
Supported by premier scientific research funding & innovation programs
